{"result": "(\"entity\"<|>POEMS<|>EVENT<|>POEMS is a syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, and skin changes, often discussed in medical literature.)\n##\n(\"entity\"<|>SÍNDROME POLIGLANDULAR AUTOINMUNE<|>EVENT<|>Syndrome of Autoimmune Polyglandular is a condition involving multiple endocrine glands and autoimmune disorders, often referenced in medical texts.)\n##\n(\"entity\"<|>ENFERMEDAD DE CASTLEMAN<|>EVENT<|>Castleman disease is a rare disorder characterized by an overgrowth of cells in the body's lymphatic system, often mentioned in medical literature.)\n##\n(\"entity\"<|>ADENOMA HIPOFISARIO<|>EVENT<|>Pituitary adenoma is a benign tumor of the pituitary gland that can affect hormone levels and is discussed in various medical contexts.)\n##\n(\"entity\"<|>INSUFICIENCIA SUPRARENAL<|>EVENT<|>Adrenal insufficiency is a condition where the adrenal glands do not produce adequate amounts of steroid hormones, commonly referenced in medical literature.)\n##\n(\"entity\"<|>HIPERPROLACTINEMIA<|>EVENT<|>Hyperprolactinemia is a condition characterized by elevated levels of prolactin in the blood, often discussed in the context of pituitary disorders.)\n##\n(\"entity\"<|>ALTERACIONES TIROIDEAS<|>EVENT<|>Thyroid disorders refer to various conditions affecting the thyroid gland, which are frequently mentioned in medical literature.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>Diabetes mellitus is a group of diseases that affect how the body uses blood sugar (glucose), widely discussed in medical contexts.)\n##\n(\"entity\"<|>HORMONAS PEPTÍDICAS<|>EVENT<|>Peptide hormones are hormones composed of amino acids that play various roles in the body, often referenced in endocrinology.)\n##\n(\"entity\"<|>HORMONAS LIPOFÍLICAS<|>EVENT<|>Lipid-soluble hormones are hormones that can pass through cell membranes and are involved in various physiological processes, commonly discussed in medical literature.)\n##\n(\"entity\"<|>RECEPTORES DE MEMBRANA<|>EVENT<|>Membrane receptors are proteins that receive chemical signals from outside the cell, playing a crucial role in cellular communication, often mentioned in medical texts.)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Monoclonales y cambios en la piel (del inglés Skin). No                      todas estas características son\n         • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper y cols, eds. Harrison Principios de Medicina Interna. 19.ª ed. McGraw-Hill;      necesarias para el diagnóstico, y hay otras no incluidas. Es muy rara (0,3 casos por cada\n           2015. p. 2309-29.\n         • Nieman LK, MD. Causes of primary adrenal insufficiency (Addison’s disease). Lacroix A, ed. UpToDate. Waltham, MA: UpToDate Inc.           100.000 habitantes).\n           https://www.uptodate.com (Last updated: Feb 20, 2019.)\n         • Welt CK. Clinical features and diagnosis of autoimmune primary ovarian insufficiency (premature ovarian failure). Barbieri RL,            Se considera un síndrome paraneoplásico de una discrasia de células plasmáticas mono-\n           Crowley WF, eds. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (Last updated: Sep 25, 2019.)                              clonales con polineuropatía, a la que se asocian otras patologías.\n                                                                                                                                                     El diagnóstico se confirma cuando están presentes los dos criterios principales obligato-\n     35  Respecto a los síndromes poliglandulares autoinmunes (SPA) señale la respuesta                                                              rios, uno de los otros tres criterios principales, y uno de los seis criterios menores (tabla 6).\n         correcta:                                                                                                                                   La neuropatía es uno de los criterios definitorios, que es periférica, ascendente, simétrica\n         A. El SPA de tipo 1 se hereda de forma autosómica dominante.                                                                                y sensitivomotora. La discrasia de células plasmáticas monoclonales es el otro criterio.\n         B. No se conoce el gen relacionado con el SPA de tipo 1.                                                                                    Las endocrinopatías aparecen en más de la mitad de los pacientes, y destacan por su fre-\n         C. El SPA de tipo 1 afecta mucho más a mujeres.                                                                                             cuencia el hipogonadismo, seguido por alteraciones tiroideas, la diabetes mellitus y otras\n         D.  El SPA de tipo 2 se asocia al antígeno de histocompatibilidad HLA-DR3.                                                                  menos     frecuentes     (insuficiencia suprarrenal, hiperprolactinemia).                No es    característica     la\n                                                                                                                                                     presencia de adenoma hipofisario.\n\n\n\n356                                                                                                                                                                                                                                                                            357\n---\n                                                                                                                                                                       GÓNADAS,                SÍNDROME POLIGLANDULAR                                                  6\n                                                                                                                                                                                            AUTOINMUNE Y                      MISCELÁNEA\n\n\n\n              Tabla 6. Criterios diagnósticos del POEMS                                                                                         COMENTARIO\n                Criterios obligatorios       • Polineuropatía                                                                                   La acción hormonal sobre células diana necesita de la interacción de la hormona con su\n                mayores                      • Discrasia de células plasmáticas monoclonales                                                    receptor, que puede encontrarse en la membrana celular o dentro de la célula.\n                Otros criterios              • Enfermedad de Castleman (hiperplasia nodular linfoide angiofolicular)                            Receptores de membrana: las hormonas peptídicas actúan sobre receptores de mem-\n                mayores                      • Lesiones escleróticas óseas                                                                      brana, generalmente activando proteínas efectoras que producen un                                segundo      mensa-\n                                             • Elevación del VEGF                                                                               jero que transmite y amplifica la señal hacia el interior de la célula. Su acción sobre las\n                                             • Organomegalia                                                                                    células diana es rápida:\n                                             • Sobrecarga de volumen extracelular                                                               •  Sistema de la adenilciclasa (AMPc como segundo mensajero): CRH, ACTH, LH, FSH, TSH,\n                Criterios menores            • Endocrinopatía                                                                                      ADH, calcitonina, PTH, glucagón, etc.\n                                             • Alteraciones dérmicas                                                                               Sistema de la fosfolipasa C (IP/Ca++como segundos mensajeros): GnRH, TRH, GHRH,\n                                             • Papiledema                                                                                       •                                            3\n                                             • Trombocitosis                                                                                       angiotensina II, etc.\n                Otros                                                                                                                           •  Sistema de la tirosina cinasa: insulina, IGF-1, GH, prolactina.\n                                                                                                                                                •  Sistema de la guanilato-ciclasa (GMPc como segundo mensajero): péptido natriurético\n              VEGF: factor de crecimiento endotelial vascular.                                                                                     auricular, óxido nítrico.\n              Referencias:                                                                                                                      Receptores intracelulares: las hormonas lipofílicas (esteroideas, tiroideas y vitamina D)\n              • Barker JM, Anderson MS, Gottllieb PA. The immunoendocrinopathy syndromes. En: Melmed S, Polonsky KS, Larsen P, Kronenberg\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>UPTODATE INC.<|>ORGANIZATION<|>UpToDate Inc. is a medical information provider that offers clinical decision support tools and resources for healthcare professionals.)\n##\n(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison's Principles of Internal Medicine is a comprehensive medical textbook widely used in the field of internal medicine.)\n##\n(\"entity\"<|>ARLT W.<|>PERSON<|>Arlt W. is an author who contributed to the medical literature on adrenal disorders.)\n##\n(\"entity\"<|>LACROIX A.<|>PERSON<|>Lacroix A. is an editor who has worked on medical publications related to adrenal insufficiency.)\n##\n(\"entity\"<|>BARBIERI RL.<|>PERSON<|>Barbieri RL. is an editor involved in the publication of medical literature on ovarian insufficiency.)\n##\n(\"entity\"<|>KASPER Y COLS.<|>PERSON<|>Kasper Y and colleagues are editors of a medical textbook that includes information on adrenal disorders.)\n##\n(\"entity\"<|>VEGF<|>EVENT<|>VEGF (Vascular Endothelial Growth Factor) is a signaling protein involved in the formation of blood vessels and is relevant in various medical conditions.)\n##\n(\"relationship\"<|>ARLT W.<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Arlt W. contributed to the medical literature referenced in Harrison's Principles of Internal Medicine<|>7)\n##\n(\"relationship\"<|>LACROIX A.<|>UPTODATE INC.<|>Lacroix A. is an editor for UpToDate Inc., which provides clinical information on adrenal insufficiency<|>8)\n##\n(\"relationship\"<|>BARBIERI RL.<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Barbieri RL. is an editor of medical literature referenced in Harrison's Principles of Internal Medicine<|>7)\n##\n(\"relationship\"<|>KASPER Y COLS.<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Kasper Y and colleagues are editors of the textbook that includes contributions from various authors<|>6)\n##\n(\"relationship\"<|>VEGF<|>UPTODATE INC.<|>VEGF is discussed in the context of medical conditions in resources provided by UpToDate Inc.<|>5)\n<|COMPLETE|>"}]}